Henkel, Covestro and Quad Industries collaborate for advanced medical wearables based on printed electronics
Combined capabilities to drive novel healthcare applications presented at MEDICA 2024
Combined capabilities to drive novel healthcare applications presented at MEDICA 2024
Tyvek with Renewable Attribution is designed to help reduce the carbon footprint
The US District Court of New Jersey decided to grant a preliminary injunction delaying the launch of LEQSELVI
This is in pursuance to the announcement made in the Union Budget for the year 2024-25 exempting these three anti-cancer medicines from customs duty
JB’s absolute Scope1 & Scope2 emissions reduced by 13.9 % in the last financial year, despite turnover increasing by 11%
GBM affects nearly 13,000 patients annually in the US and approximately 300,000 globally
The partnership marks a pivotal step towards developing new therapies for combating Sickle Cell Disease
SIBUR is developing a special grade of polycarbonate compatible with radiation sterilization
The report highlights Piramal Pharma’s approach across four key strategic pillars: Responsible Operations, Business Resilience, Customer Centricity, and Quality & Excellence
At 10 years, more than one-third (34.0%) of patients with advanced melanoma were alive after treatment with KEYTRUDA, compared to 23.6% of patients treated with ipilimumab
Subscribe To Our Newsletter & Stay Updated